Back to search
Visual Field Defect
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Visual Field Defect trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Visual Field Defect trials you may qualify forVisual field defects are a common consequence of acquired brain injuries and affect people of all ages. These vision problems make everyday life more difficult-…
This is a research study to evaluate the effectiveness of the PAVE (Parallactic Visual-Field Enhancement) System for the treatment of chronic visual field loss…
In patients with hemianopsia following stroke or brain injury, we will determine if stimulating the visual field with images from a PowerPoint slide set can inc…
Glaucoma is a progressive optic neuropathy with retinal ganglion cell loss which leads to visual field loss. Open-angle glaucoma is the most common form of glau…
This is a randomized, pilot interventional study in participants with visual field deficit (VFD) caused by cortical lesion. Damage to the primary visual cortex…
The purpose of this research is to better understand the impact of cortically-induced blindness (CB) and the compensatory strategies subjects with this conditio…
This pilot clinical trial evaluates whether non-invasive brain stimulation improves the orientation and mobility (O\&M) skills of individuals with constricted v…
Background: Homonymous hemianopia is a visual field defect that causes functional disabilities, such as decreased self-confidence, limited mobility, and increas…
Group 4a and 4b was an FDA trial that showed that patients who have an Amsler grid abnormality on paper, have a similar abnormality on the app. Group 7a and 7b…